Get the Stockscreener App
2.38
2.15%
0.05
After Hours:
2.35
-0.03
-1.26%
Alpha Tau Medical Ltd stock is traded at $2.38, with a volume of 58,987.
It is up +2.15% in the last 24 hours and down -2.86% over the past month.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.
See More
Previous Close:
$2.33
Open:
$2.35
24h Volume:
58,987
Relative Volume:
1.79
Market Cap:
$160.83M
Revenue:
-
Net Income/Loss:
$-28.95M
P/E Ratio:
-7.4375
EPS:
-0.32
Net Cash Flow:
$-29.35M
1W Performance:
+3.93%
1M Performance:
-2.86%
6M Performance:
-19.32%
1Y Performance:
-37.20%
1-Day Range:
$2.26
$2.38
1-Week Range:
$2.26
$2.38
52-Week Range:
$1.75
$3.90
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-14-22 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-08-22 | Initiated | Piper Sandler | Overweight |
| Apr-04-22 | Initiated | Citigroup | Buy |
Alpha Tau Medical Ltd Stock (DRTS) Latest News
Radiopharmaceutical Market 2024 – Industry Opportunities, Challenges, Value Chain and Sales Channels Analysis 2032 | Clarity Pharmaceuticals - 대구포스트
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Update - MarketBeat
Alpha Emitter Market Outlook, Key Trends and Growth Projections from 2024 to 2032 - 대구포스트
Alpha Emitter Market on the Rise: A Study on its Growth Prospects - openPR
Alpha Tau Medical Ltd.FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT in Immunocompromised Patients with Recurrent cSCC - Marketscreener.com
FDA approves study of Alpha Tau’s Alpha DaRT for recurrent cSCC treatment - Yahoo Finance
Global Alpha Emitter Market Set to Reach $ 1751.5 Million by 2032, Expanding at 11.25% CAGR - 대구포스트
Alpha Tau’s Alpha DaRT Gains FDA Study Approval - TipRanks
Alpha Tau Medical Ltd. Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT in Immunocompromised Patients with Recurrent cSCC - Marketscreener.com
Alpha Tau Announces FDA Approval of IDE to Initiate - GlobeNewswire
Sidoti Events, LLC's Virtual September Small-Cap Conference - Yahoo Finance
Alpha Tau Medical’s Alpha DaRT Technology Shows Breakthrough Results in Cancer Trials - Proactive Investors Australia
Alpha Tau Medical Share PriceDRTS, RNS News, Articles, Quotes, & Charts (NASDAQ:DRTS) - Proactive Investors Australia
23,323 Shares in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Purchased by Caprock Group LLC - Defense World
Alpha Tau Medical (NASDAQ:DRTSW) Trading Down 5.3% - Defense World
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 63.4% in August - MarketBeat
Top 230+ startups in Radiation Therapy Devices in Sep, 2024 - Tracxn
Radiotherapy Devices Market Scope In The New Analysis By Leading Research Firm - WhaTech
Kromek Group (LON:KMK) Share Price Passes Below 200-Day Moving Average of $6.56 - Defense World
Aptus Capital Advisors LLC Raises Holdings in Alpha Tau Medical Ltd. (NASDAQ:DRTS) - Defense World
Aptus Capital Advisors LLC Sells 1,326 Shares of JPMorgan Municipal ETF (BATS:JMUB) - Defense World
Medical Lasers Market 2024: Exploring Industry Demand, Technological Advancements, And Future Prospects - WhaTech
Oncology Devices Market Key Trends, Latest Insights, Future Trends And Forecast To 2033 - WhaTech
DRTS: Company Seeks to Develop Significant Advance in Cancer Therapy with Alpha DaRT - Yahoo Finance
Financial Comparison: Assure (NASDAQ:IONM) versus Alpha Tau Medical (NASDAQ:DRTS) - Defense World
HP Inc. (NYSE:HPQ) Shares Sold by Cambridge Investment Research Advisors Inc. - Defense World
Capital Group Dividend Growers ETF (NYSEARCA:CGDG) Stock Position Lifted by Cambridge Investment Research Advisors Inc. - Defense World
Alpha Tau Medical (NASDAQ:DRTSW) Stock Price Up 10.3% - Defense World
Alpha Tau Medical Ltd. Forecasted to Post FY2024 Earnings of ($0.47) Per Share (NASDAQ:DRTS) - MarketBeat
Alpha Tau Medical to Showcase Cancer Therapy at Global Conferences - TipRanks
Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Invest - Marketscreener.com
Alpha Tau to Participate in the H.C. Wainwright 26th Annual - GlobeNewswire
Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Invest - StockTitan
Alpha Tau Medical Ltd. to Post FY2024 Earnings of ($0.47) Per Share, HC Wainwright Forecasts (NASDAQ:DRTS) - Defense World
SIR Royalty Income Fund (TSE:SRV.UN) Shares Cross Below Two Hundred Day Moving Average of $13.70 - Defense World
PositiveID (OTCMKTS:PSID) Shares Cross Above 200-Day Moving Average of $0.00 - Defense World
Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Invest - Yahoo Finance
Burlington Stores (BURL) to Release Quarterly Earnings on Thursday - Defense World
Alpha Tau Medical stock holds Buy rating on clinical trial updates - Investing.com India
Alpha Tau Medical stock holds Buy rating on clinical trial updates - Investing.com
Alpha Tau Medical’s (DRTS) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
SelectQuote, Inc. (NYSE:SLQT) Stock Position Decreased by California State Teachers Retirement System - Defense World
Alpha Tau Medical's (DRTS) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Bank of America Increases Lumentum (NASDAQ:LITE) Price Target to $50.00 - Defense World
8X8 (NASDAQ:EGHT) Downgraded by StockNews.com - Defense World
Alpha Tau Medical (NASDAQ:DRTS) Rating Reiterated by Piper Sandler - Defense World
StockNews.com Initiates Coverage on CVD Equipment (NASDAQ:CVV) - Defense World
Alpha Tau Medical maintains stock target with Overweight rating on operating loss - Investing.com Australia
Piper Sandler Reaffirms "Overweight" Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat
Alpha Tau Medical maintains stock target with Overweight rating on operating loss - Investing.com Canada
Alpha Tau Medical maintains stock target with Overweight rating on operating loss - Investing.com
Alpha Tau Medical Ltd Stock (DRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):